Your browser doesn't support javascript.
loading
Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7.
Luo, Yang; de Lange, Katrina M; Jostins, Luke; Moutsianas, Loukas; Randall, Joshua; Kennedy, Nicholas A; Lamb, Christopher A; McCarthy, Shane; Ahmad, Tariq; Edwards, Cathryn; Serra, Eva Goncalves; Hart, Ailsa; Hawkey, Chris; Mansfield, John C; Mowat, Craig; Newman, William G; Nichols, Sam; Pollard, Martin; Satsangi, Jack; Simmons, Alison; Tremelling, Mark; Uhlig, Holm; Wilson, David C; Lee, James C; Prescott, Natalie J; Lees, Charlie W; Mathew, Christopher G; Parkes, Miles; Barrett, Jeffrey C; Anderson, Carl A.
Afiliação
  • Luo Y; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
  • de Lange KM; Division of Genetics and Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Jostins L; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
  • Moutsianas L; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
  • Randall J; Wellcome Trust Centre for Human Genetics, University of Oxford, Headington, UK.
  • Kennedy NA; Christ Church, University of Oxford, St Aldates, UK.
  • Lamb CA; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
  • McCarthy S; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
  • Ahmad T; Precision Medicine Exeter, University of Exeter, Exeter, UK.
  • Edwards C; IBD Pharmacogenetics, Royal Devon and Exeter Foundation Trust, Exeter, UK.
  • Serra EG; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne.
  • Hart A; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
  • Hawkey C; Precision Medicine Exeter, University of Exeter, Exeter, UK.
  • Mansfield JC; IBD Pharmacogenetics, Royal Devon and Exeter Foundation Trust, Exeter, UK.
  • Mowat C; Department of Gastroenterology, Torbay Hospital, Torbay, Devon, UK.
  • Newman WG; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
  • Nichols S; Department of Medicine, St Mark's Hospital, Harrow, Middlesex, UK.
  • Pollard M; Nottingham Digestive Diseases Centre, Queens Medical Centre, Nottingham, UK.
  • Satsangi J; Institute of Human Genetics, Newcastle University, Newcastle upon Tyne, UK.
  • Simmons A; Department of Medicine, Ninewells Hospital and Medical School, Dundee, UK.
  • Tremelling M; Genetic Medicine, Manchester Academic Health Science Centre, Manchester, UK.
  • Uhlig H; The Manchester Centre for Genomic Medicine, University of Manchester, Manchester, UK.
  • Wilson DC; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
  • Lee JC; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
  • Prescott NJ; Gastrointestinal Unit, Wester General Hospital University of Edinburgh, Edinburgh, UK.
  • Lees CW; Translational Gastroenterology Unit, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK.
  • Mathew CG; Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.
  • Parkes M; Gastroenterology & General Medicine, Norfolk and Norwich University Hospital, Norwich, UK.
  • Barrett JC; Translational Gastroenterology Unit and the Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
  • Anderson CA; Paediatric Gastroenterology and Nutrition, Royal Hospital for Sick Children, Edinburgh, UK.
Nat Genet ; 49(2): 186-192, 2017 Feb.
Article em En | MEDLINE | ID: mdl-28067910
ABSTRACT
To further resolve the genetic architecture of the inflammatory bowel diseases ulcerative colitis and Crohn's disease, we sequenced the whole genomes of 4,280 patients at low coverage and compared them to 3,652 previously sequenced population controls across 73.5 million variants. We then imputed from these sequences into new and existing genome-wide association study cohorts and tested for association at ∼12 million variants in a total of 16,432 cases and 18,843 controls. We discovered a 0.6% frequency missense variant in ADCY7 that doubles the risk of ulcerative colitis. Despite good statistical power, we did not identify any other new low-frequency risk variants and found that such variants explained little heritability. We detected a burden of very rare, damaging missense variants in known Crohn's disease risk genes, suggesting that more comprehensive sequencing studies will continue to improve understanding of the biology of complex diseases.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Adenilil Ciclases / Predisposição Genética para Doença Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Adenilil Ciclases / Predisposição Genética para Doença Idioma: En Ano de publicação: 2017 Tipo de documento: Article